Effects of Cisapride on Symptoms and Postcibal Small-Bowel Motor Function in Patients with Irritable Bowel Syndrome

References

• Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel syndrome. Br Med J 1978;2:653–4.
   PubMed Web of Science ®Google Scholar
• Thompson WG, Dotevell G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1982;2:92–5.
   Google Scholar
• Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology 1990;98: 1208–18.
   Google Scholar
• Kumar D, Wingate DL. The irritable bowel syndrome: a paroxysmal motor disorder. Lancet 1985;2:973–7.
   PubMed Web of Science ®Google Scholar
• Kellow JE, Phillips SF, Miller LJ, Zinsmeister AR. Dysmotility of the small intestine in irritable bowel syndrome. Gut 1988;29:1236–43.
   PubMed Web of Science ®Google Scholar
• Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987;92:1885–93.
   PubMed Web of Science ®Google Scholar
• Gorard DA, Libby GW, Farthing MJG. Ambulatory small intestinal motility in diarrhoea predominant irritable bowel syndrome. Gut 1994;35:203–10.
   Google Scholar
• Schmidt T, Hackelsberger N, Widmer R, Meisel C, Pfeiffer A, Kaess H. Ambulatory 24-hour jejunal motility in diarrhoea-predominant irritable bowel syndrome. Scand J Gastroenterol 1996;31:581–9.
   PubMed Web of Science ®Google Scholar
• Small PK, Loudon MA, Haub CM, Noor N, Campbell FC. Large scale study of postprandial jejunal motility in irritable bowel syndrome. Scand J Gastroenterol 1997;32:39–47.
   Google Scholar
• Lucey MR, Clark ML, Lowndes J, Dawson AM. Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study. Gut 1987;28:221–5.
   PubMed Web of Science ®Google Scholar
• Prior A, Whorwell PJ. Double blind study of ispaghula in irritable bowel syndrome. Gut 1987;28:1510–3.
   PubMed Web of Science ®Google Scholar
• Centonze V, Imbimbo BP, Campanozzi F, Attolini E, Daniotti S, Albano O. Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome. Am J Gastroenterol 1988;83:1262–6.
   PubMedGoogle Scholar
• Dobrilla G, Imbimbo BP, Piazzi L, Bensi G. Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial. Gut 1990;31:355–8.
   PubMedGoogle Scholar
• Christen MO. Action of pinaverium bromide, a calciumantagonist, on gastrointestinal motility disorders [review]. Gen Pharmacol 1990;21:821–5.
   PubMedGoogle Scholar
• Stefanini GF, Saggioro A, Alvisi V, Angelini G, Capurso L, di Lorenzo G, et al. Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients. Scand J Gastroenterol 1995; 30:535–41.
   Google Scholar
• Stefanini GF, Prati E, Albini MC, Piccinini G, Capelli S, Castelli E, et al. Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrhoea type. Am J Gastroenterol 1992;87:55–7.
   PubMed Web of Science ®Google Scholar
• Van Outryve M, Milo R, Toussaint J, Van Eeghem P. ‘Prokinetic’ treatment of constipation-predominant irritable bowel syndrome: a placebo-controlled study of cisapride. J Clin Gastroenterol 1991;13:49–57.
   Google Scholar
• Tack J, Coremans G, Janssens J. A risk-benefit assessment of cisapride in the treatment of gastrointestinal disorders [review]. Drug Safety 1995;12:384–92.
   Google Scholar
• Longo WE, Vernava AM 3d. Prokinetic agents for lower gastrointestinal motility disorders [Review]. Dis Colon Rectum 1993;36:696–708.
   PubMed Web of Science ®Google Scholar
• Coremans G, Janssens J, Vantrappen G, Chaussade S, Ceccatelli P. Cisapride stimulates propulsive motility patterns in human jejunum. Dig Dis Sci 1988;33:1512–9.
   Google Scholar
• Stacher G, Gaupmann G, Mittelbach G, Schneider C, Steinringer H, Langer B. Effects of oral cisapride on interdigestive jejunal motor activity, psychomotor function, and side-effect profile in healthy man. Dig Dis Sci 1987;32:1223–30.
   PubMedGoogle Scholar
• Benson MJ, Castillo FD, Deeks JJ, Wingate DL. Assessment by prolonged ambulatory manometry of the effect of oral cisapride on proximal small bowel inter-digestive motility. Dig Dis Sci 1992;37:1569–75.
   PubMedGoogle Scholar
• Waldron B, Smith B, Storey BE, White G, Campbell FC. Development and validation of microcomputer analysis of gastric and small bowel manometry. J Gastrointest Motil 1992; 4:301–15.
   Google Scholar
• Lindberg G, Iwarzon M, Stal P, Seensalu R. Digital ambulatory monitoring of small bowel motility. Scand J Gastroenterol 1990; 25:216–24.
   PubMed Web of Science ®Google Scholar
• Siler W. Hybrid computers in bioscience. In: Stacey RW, Waxman BD, editors. Computers in biomedical research. Vol 1. New York: Academic Press; 1965. p. 87–108.
   Google Scholar
• ACG Committee on FDA-Related matters with primary authorship by McCallum RW. Cisapride: a new class of prokinetic agent. Am J Gastroenterol 1991;86:135–49.
   PubMedGoogle Scholar
• Nameth PR, Gullikson GW. Gastrointestinal motility stimulating drugs and 5HT receptors on myenteric neurons. Eur J Pharmacol 1989;166:387–91.
   PubMedGoogle Scholar
• Tonini M, Rizzi CA, Manzol L, Onori L. Novel enteric 5HT4 receptors and gastrointestinal prokinetic action. Pharm Res 1991;24:5–14.
   Google Scholar
• Dumuis A, Sebben M, Bockaert J. BRL24924: a potent agonist at nonclassical 5HT receptor positively coupled with adenylate cyclase in colliculi neurons. Eur J Pharmacol 1989;162: 381–4.
   Google Scholar
• Dumuis A, Sebben M, Bockaert J. The gastrointestinal prokinetic benzamide derivatives are agonists at the nonclassical 5HT receptors positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol 1989;340: 403–10.
   Google Scholar
• Schuurkers JAJ, Van Nueten JM, Van Daele PGH, Reyntjens AJ, Janssen PAJ. Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther 1985;234:776–83.
   Google Scholar
• Stacher G, Gaupmann G, Steinringer H, Schneider C, Stacher-Janotta G, Steiner-Mittelbach G, et al. Effects of cisapride on postcibal jejunal motor activity. Dig Dis Sci 1989;34:1405–10.
   Google Scholar
• Muller-Lissner SA, the Bavarian Constipation Study Group. Treatment of chronic constipation with cisapride and placebo. Gut 1987;28:1033–38.
   Google Scholar